Dr. Hal T Liddell, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 139 Fairfield Dr, Hattiesburg, MS 39402 Phone: 601-450-2401 Fax: 601-450-2433 |
John Moore, Urology Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5888 Fax: 601-261-3587 |
Sean Philip Douglas, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5888 Fax: 601-579-5240 |
Dr. Nathan P Shappley, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 101 Aldersgate Cir, Hattiesburg, MS 39402 Phone: 601-261-5800 Fax: 601-261-5813 |
Bradley N Secrest, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5888 Fax: 601-261-3587 |
Woodie J Wilson Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5888 Fax: 601-261-3587 |
David C Stout, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 4 Pebble Crk, Hattiesburg, MS 39402 Phone: 601-261-9323 |
Randolph J Ross, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2 Morgans Lndg, Hattiesburg, MS 39402 Phone: 601-268-0258 |
Kaitlen Sicard Schexnayder, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5888 Fax: 601-261-3587 |
John M Guice, MD Urology Medicare: Medicare Enrolled Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5888 Fax: 601-261-3587 |
News Archive
Scientists at the Massachusetts General Hospital (MGH) have developed a molecular imaging probe to reveal Alzheimer's disease (AD)-related γ-secretase in rodents and macaques with translational potentials in humans.
Screening for a panel of gene variants associated with the risk for type 2 diabetes can identify adults at risk for the disorder but is not significantly better than assessment based on traditional risk factors such as weight, blood pressure and blood sugar levels.
A small cluster of unusual illnesses at a Colorado children's hospital prompted an investigation that swiftly identified alcohol prep pads contaminated with Bacillus cereus bacteria, according to a report in the July issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
BioScrip, Inc. announced 2010 second quarter revenue of $412.0 million, operating income of $13.5 million and net income of $3.1 million, or $0.06 per diluted share. Second quarter adjusted earnings per share (detailed in schedule 5) was $0.07 per diluted share. Adjusted EBITDA for the quarter was $18.4 million. All 2010 per share amounts have been adjusted to reflect the Company's issuance of 13.1 million shares in conjunction with the acquisition of CHS.
› Verified 9 days ago